WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck ® , a diagnostic test for peripheral neuropathy, will be introduced at the 20 th Scientific Meeting of the Chinese Diabetes Society during November 16-19, 2016 in Xiamen , Fujian, China .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Senior Vice President and Chief Commercial Officer Frank McGillin will present on Quell ® Wearable Pain Relief Technology™ during the 16th Annual Diabetes Technology Meeting, November 10-12 , in
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that it has promoted Frank McGillin to Senior Vice President and Chief Commercial Officer. Mr. McGillin's most recent title was Senior Vice President and GM Consumer. In the expanded role, Mr.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,474,898. The patent covers key technology that enables safe delivery of Quell ® therapy for chronic pain while the user is sleeping.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix , is scheduled to speak at the 2016 Sidoti Emerging Growth Convention at the Marriott Marquis in New York City on
Revenue up 65% year-over-year to $3.4 Million New quarterly highs for Quell device shipments and electrode reorders DPNCheck shipments reached 4 year high of 57,400 biosensors WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) reported today that it will be an active participant at the Connected Health Symposium on October 20-21 in Boston sponsored by Partners Healthcare . Shai N. Gozani M.D ., Ph.D., President and CEO of NeuroMetrix , will be a
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that it plans to issue its 2016 third quarter financial results before the opening of the market on Thursday, October 20, 2016. The Company will host a conference call at 8:00 a.m., Eastern Time on October
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) reported today that it has been selected to showcase Quell ® Wearable Pain Relief Technology™ at the Discover Blue: New York City event hosted by the Bluetooth Special Interest Group on October 12 th .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today announced that Dr. Xuan Kong, SVP, Research and Intellectual Property, will present the Company's DPNCheck ® technology at the 5 th Annual Diabetic Peripheral Neuropathy Fellowship for Chinese Physicians at the
